Most Popular
-
1
Two jailed for forcing disabled teens into prostitution
-
2
Trump picks ex-N. Korea policy official as his principal deputy national security adviser
-
3
Russia sent 'anti-air' missiles to Pyongyang, Yoon's aide says
-
4
S. Korea not to attend Sado mine memorial: foreign ministry
-
5
North Korean leader ‘convinced’ dialogue won’t change US hostility
-
6
Hyundai Motor’s Genesis US push challenged by Trump’s tariff hike: sources
-
7
Toxins at 622 times legal limit found in kids' clothes from Chinese platforms
-
8
[Weekender] Korea's traditional sauce culture gains global recognition
-
9
BLACKPINK's Rose stays at No. 3 on British Official Singles chart with 'APT.'
-
10
Oasis confirms first Korean concert in 16 years
-
Celltrion seeks sales approval for anticancer biosimilar in Europe
South Korean drugmaker Celltrion said Tuesday that the company has submitted an application to the European Medicines Agency for approval of the sale of its anti-cancer biosimilar candidate CT-P16. CT-P16 is a biosimilar of Roche’s Avastin, an anti-cancer treatment that kills cancer cells by preventing the growth of blood vessels. Avastin, which can treat numerous cancers, including metastatic colorectal cancer, has been Roche’s bestselling cancer drug. The patents on Avastin, h
Oct. 12, 2021
-
More IT devices opt for Korean OLED displays
Organic light-emitting diode displays largely produced by South Korea’s leading panel makers LG Display and Samsung Display are being deployed in more devices, squeezing out cheaper liquid crystal displays at a remarkable rate. As the market for the thinner and more flexible display panels expands, Apple is planning to adopt OLED panels for its new iPad series scheduled for 2023 for the first time, industry sources said Monday. Apple has sourced OLED panels for iPhones from both LG and
Oct. 12, 2021
-
LGE sees record Q3 sales, but operating profit halved on GM EV recall
LG Electronics is expected to report its highest-ever quarterly sales in the third quarter of this year, but a sharply lower operating profit due to provision expenses for a US recall. The South Korean electronics firm on Tuesday announced its earnings guidance for the July-September period -- 18.7 trillion won ($15.5 billion) in estimated revenue and 540.7 billion won in estimated operating profits. LG Electronics’ revenue exceeded a previous record set in the second quarter of this y
Oct. 12, 2021
-
Samsung Biologics signs CDMO deal with US-based drugmaker
Samsung Biologics said Thursday that it had signed a contract development and manufacturing organization deal with Texas-based drugmaker Enzolytics. The company did not disclose the financial terms. Under the deal, Samsung Biologics will provide end-to-end CDMO services to help Enzolytics develop and manufacture investigational new drug treatments for HIV and COVID-19. Samsung Biologics said it would provide a stable cell line from its research and development facility in San Francisco, whi
Oct. 8, 2021
-
Samsung Electronics expects to post all-time high earnings in Q3
Samsung Electronics said Friday that the company expected to log quarterly sales of 73 trillion won ($61.2 billion), up 9 percent from a year ago, surpassing 70 trillion won for the first time in the company’s history. The previous record in quarterly sales for the firm was 66.9 trillion won, set in the third quarter of 2020. According to Samsung’s earnings guidance, its operating profit during the July-September period has also increased 27.94 percent on-year, or by 15.8 trillio
Oct. 8, 2021
-
UN climate change tech unit to open office in Songdo
A United Nations’ climate change body will open an office in Songdo, Incheon, in March, the Ministry of Science and ICT said Thursday. Science Minister Lim Hye-sook and Incheon Mayor Park Nam-choon signed an agreement with UN Environment Program Executive Director Inger Andersen to bring the Climate Technology Center and Network’s partnership and liaison office to Korea. The CTCN is the operational arm of the United Nations Framework Convention on Climate Change Technology Mechan
Oct. 7, 2021
-
[Newsmaker] ABL Bio begins clinical trial of anticancer drug candidate
South Korean biotech firm ABL Bio said Thursday that it has begun the phase 1 clinical trial of anticancer drug candidate ABL501. ABL501 is an antibody that uses the Grabody-I platform technology to block both the PD-L1 and LAG-3 checkpoint pathways, improving the current limitation in PD-L1 therapies. ABL Bio said the company has administered the drug candidate to the first patient with a solid tumor at Samsung Medical Center in Seoul. An official from ABL Bio said the phase 1 clinical tria
Oct. 7, 2021
-
Samsung introduces industry’s first open-source solution for CXL memory platform
Samsung Electronics said Thursday it is unveiling an open-source software solution specially designed to expand the use of the compute express link memory platform. Dubbed a “scalable memory development kit,” or SMDK, it is the industry’s first solution for customers of the relatively new memory platform CXL developed by Samsung in May. CXL is an open interconnect standard that allows not only CPUs but also other high-performance computing system such as artificial intellige
Oct. 7, 2021
-
Korean edtech startups race to catch up with global rivals in robot education
South Korea has been implementing a set of educational policies aimed at helping students and teachers prepare for digital transformation in a wide array of fields. The pandemic that started last year is accelerating the shift in the educational sector toward a digital paradigm, requiring schools and policymakers to rethink the way they teach students as well as what they should teach in a new era. The Korean government, recognizing the sweeping changes sparked by the spread of COVID-19, is
Oct. 6, 2021
-
Edtech startup Alux aims to take lead in next-generation educational robots
Alux, a startup in the fast-growing field of educational technology, or edtech, is providing next-generation education programs based on big data, artificial intelligence and the metaverse to some 2,000 schools across the country. Lee Chi-heon, CEO of Alux, said the Seoul-based startup is navigating a whirlwind of changes in the education market, sparked by a pandemic-induced switch from offline programs to what is called “untact” alternatives, referring mainly to contactless
Oct. 6, 2021
-
Samsung foldable phones hit 1 million in sales volume in Korea
The sales volume of Galaxy Z Fold3 and Flip3 has surpassed 1 million in South Korea, according to Samsung Electronics on Wednesday. The tech giant said the total number of units of the two foldable devices sold in the Korean market reached 1 million Monday, 39 days since their debut on Aug. 11. The foldable phones trailed only Samsung’s biggest hits of the Galaxy Note 10 and flagship Galaxy S8 in the pace of reaching the 1 million mark. Of the 1 million units, about 70 percent are
Oct. 6, 2021
-
LG Innotek showcases new substrate products at KPCA show
LG Innotek said Wednesday the company is taking part in an international trade show for substrates and chip packaging technologies to showcase its newest products and technologies. The electronic parts supplier of LG Group exhibited three new products -- 5G Antenna in Package, RF-System in Package and Chip On Film -- at the Korea International Electronic Circuits and Packaging Show 2021 that kicked a three-day run in Songdo, Incheon on Wednesday. The 5G AiP is a substrate for the antenna mod
Oct. 6, 2021
-
Trade minister voices concerns over chip info disclosure
South Korea’s Trade Minister Yeo Han-koo expressed concern over the US request on Korean chipmakers to disclose sensitive information about technology, clients and inventories, during his meeting Tuesday with US counterpart Katherine Tai, officials in Seoul said Wednesday. Yeo, who is currently attending a council meeting of the Organization for Economic Co-operation and Development in Paris, held bilateral talks with the US trade representative, where he relayed such opinion from local
Oct. 6, 2021
-
SK Bioscience renews vaccine deal with CEPI
South Korean drugmaker SK Bioscience announced Wednesday the company has updated its capacity reservation contract with the Coalition for Epidemic Preparedness Innovations. Under the new agreement, CEPI can use part of SK Bioscience’s Andong production facility until 2022 for manufacturing COVID-19 vaccines. SK Bioscience’s factory in Andong, North Gyeongsang Province, currently has a total of nine production lines that can produce drug substances for COVID-19 vaccines. Of the to
Oct. 6, 2021
-
Quarter of S. Korean mobile users subscribed to 5G: data
Around a quarter of South Korea's mobile subscriptions were on 5G networks in August, data showed Wednesday, as new smartphone launches boosted user growth in the latest generation networks. As of end-August, there were 17.8 million 5G network users, accounting for 24.8 percent of the country's total 71.9 million mobile network subscriptions, according to the data from the Ministry of Science and ICT. South Korea has a population of 51 million, and some people have multiple mobile phones. The
Oct. 6, 2021
-
Phone market to grow slowly amid parts shortages
Despite recent releases from Samsung Electronics and Apple featuring the most advanced technologies so far, the global smartphone market is forecast to grow slowly as phone vendors struggle to secure components, including semiconductors, amid ongoing shortages worldwide. According to a recent report from market researcher Counterpoint Research, the total shipment volume of smartphones for 2021 is expected to grow 6 percent to 1.41 billion units. The growth forecast was lowered from the resea
Oct. 5, 2021
-
Samsung Electronics kicks off wage negotiation with union
Samsung Electronics and its unions held their first wage talks Tuesday at the company’s plant in Yongin, Gyeonggi Province, industry sources said. Samsung‘s management and the unions will continue their negotiations in the following weeks to decide changes to union members’ terms of employment. Unionized workers have demanded a uniform raise in salary by 10 million won ($8,400), plus cash and stock bonuses worth 4.5 million won in total. The union also requests managemen
Oct. 5, 2021
-
[Feature] AI job interviews are booming, but doubts linger
Interviews are a crucial part of the job search process. But what if you were to be evaluated by a machine, rather than human interviewers? As digital transformation changes the way businesses get done, accelerated by the contactless trend of the pandemic era, artificial intelligence programs that screen or evaluate job candidates are booming in Korea, as well as elsewhere in the world. A typical AI-operated interview usually requires candidates to sit through a set of online games and video
Oct. 4, 2021
-
Top food delivery app Baemin is the least senior-friendly: report
The country‘s largest food delivery firm Baedal Minjok has been selected as the least accessible and friendly application for older people and those with disabilities, a local lawmaker said Monday. According to lawmaker Yang Jeong-suk, who quoted the Ministry of Science and ICT’s report, Baemin ranked at the bottom among the top 300 most-downloaded apps that the ministry reviewed. The 300 apps were evenly split -- with a half available for Apple and the other half for Android. The
Oct. 4, 2021
-
S. Korean HIV medicine to be sold in China
Korea Research Institute of Chemical Technology announced Thursday that a domestically developed HIV medicine has recently received regulatory approval for commercialization in China. This new medicine was first developed by a local research team as part of a project started in 1995, supported by the Ministry of Science and ICT. In 2006, US pharmaceutical firm Gilead Sciences joined the project and co-developed a treatment candidate in 2008. The technology was sold to local biotech firm Kain
Sept. 30, 2021